Hypophosphataemia after treatment of iron deficiency with intravenous ferric carboxymaltose or iron isomaltoside—a systematic review and meta‐analysis

AIMS: Hypophosphataemia is an increasingly recognized side‐effect of ferric carboxymaltose (FCM) and possibly iron isomaltoside/ferric derisomaltose (IIM), which are used to treat iron deficiency. The aim of this study was to determine frequency, severity, duration and risk factors of incident hypop...

Descripción completa

Detalles Bibliográficos
Autores principales: Schaefer, Benedikt, Tobiasch, Moritz, Viveiros, André, Tilg, Herbert, Kennedy, Nicholas A., Wolf, Myles, Zoller, Heinz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Systematic Review and Meta‐analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247006/
https://www.ncbi.nlm.nih.gov/pubmed/33188534
http://dx.doi.org/10.1111/bcp.14643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247006/
https://www.ncbi.nlm.nih.gov/pubmed/33188534
http://dx.doi.org/10.1111/bcp.14643

Ejemplares similares